Bispecific Antibody Therapeutics Market size was valued at USD 523.9 Million in 2021 and is projected to reach USD 963.3 Million by 2030, growing at a CAGR of 7.0% from 2022 to 2030.

In a single molecule, bispecific antibodies have two antigen-binding sites. Bispecific antibodies appear in a variety of sizes and shapes, ranging from tiny proteins with two associated antigen-binding fragments to massive IgG-like molecules with addition...

In a single molecule, bispecific antibodies have two antigen-binding sites. Bispecific antibodies appear in a variety of sizes and shapes, ranging from tiny proteins with two associated antigen-binding fragments to massive IgG-like molecules with addition...

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community